EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 1 (Janvier 2013) Med Sci (Paris), 29 1 (2013) 22-25 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 1, Janvier 2013
Page(s) 22 - 25
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013291007
Published online 25 January 2013
  1. Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 2012 ; 337 : 183–186. [CrossRef] [PubMed] [Google Scholar]
  2. Corti D, Voss J, Gamblin ST, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011 ; 333 : 850–856. [CrossRef] [PubMed] [Google Scholar]
  3. Dreyfus C, Laursen NS, Kwaks T, et al. Highly conserved protective epitopes on influenza B viruses. Science 2012 ; 337 : 1343–1348. [CrossRef] [PubMed] [Google Scholar]
  4. Ekiert DC, Bhabha G, Elsliger MA, et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009 ; 324 : 246–251. [CrossRef] [PubMed] [Google Scholar]
  5. Ekiert DC, Friesen RH, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011 ; 333 : 843–850. [CrossRef] [PubMed] [Google Scholar]
  6. Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Biol 2009 ; 16 : 265–273. [CrossRef] [Google Scholar]
  7. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004 ; 78 : 12817–12828. [CrossRef] [PubMed] [Google Scholar]
  8. Throsby M, van den Brink E, Jongeneelen M, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1, H1N1 recovered from human IgM+ memory B cells. PLoS One 2008 ; 3 : e3942. [CrossRef] [PubMed] [Google Scholar]
  9. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004 ; 292 : 1333–1340. [CrossRef] [PubMed] [Google Scholar]
  10. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000 ; 355 : 827–835. [CrossRef] [PubMed] [Google Scholar]
  11. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007 ; 449 : 101–104. [CrossRef] [PubMed] [Google Scholar]
  12. Fleishman SJ, Whitehead TA, Ekiert DC, et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 2011 ; 332 : 816–821. [CrossRef] [PubMed] [Google Scholar]
  13. Whitehead TA, Chevalier A, Song Y, et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol 2012 ; 30 : 543–548. [CrossRef] [PubMed] [Google Scholar]
  14. Bao Y, Bolotov P, Dernovoy D, et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008 ; 82 : 596–601. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.